Nonetheless, ET-1 can trigger resistance to bortezomib in human MM cells, and it has been suggested that ET-1 might be a key factor involved in the escape mechanism in MM patients treated with bortezomib (Vaiou et al., 2016). The gene discussed is EDN1; the disease is Miyoshi myopathy.